Focused Wealth Management, Inc Sarepta Therapeutics, Inc. Transaction History

Focused Wealth Management, Inc

$746 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$117.53 - $155.99 $12,928 - $17,158	-110 Reduced 73.33%	40 $5,000
Q3 2022 Oct 20, 2022	SELL	$75.71 - $119.24 $12,265 - $19,316	-162 Reduced 51.92%	150 $17,000
Q2 2022 Aug 04, 2022	SELL	$62.69 - $88.44 $62 - $88	-1 Reduced 0.32%	312 $23,000
Q1 2022 Apr 29, 2022	SELL	$63.15 - $90.42 $167,726 - $240,155	-2,656 Reduced 89.46%	313 $24,000
Q4 2021 Jan 31, 2022	SELL	$77.28 - $99.42 $30,371 - $39,072	-393 Reduced 11.69%	2,969 $267,000
Q3 2021 Oct 12, 2021	SELL	$65.97 - $92.48 $16,690 - $23,397	-253 Reduced 7.0%	3,362 $311,000
Q2 2021 Jul 15, 2021	SELL	$69.38 - $86.75 $28,237 - $35,307	-407 Reduced 10.12%	3,615 $281,000
Q1 2021 May 03, 2021	BUY	$72.25 - $168.95 $176,145 - $411,900	2,438 Added 153.91%	4,022 $300,000
Q4 2020 Feb 03, 2021	SELL	$125.56 - $178.74 $36,914 - $52,549	-294 Reduced 15.65%	1,584 $270,000
Q3 2020 Oct 19, 2020	SELL	$127.12 - $172.34 $694,710 - $941,838	-5,465 Reduced 74.42%	1,878 $264,000
Q2 2020 Jul 24, 2020	SELL	$93.0 - $171.7 $6,789 - $12,534	-73 Reduced 0.98%	7,343 $1.18 Million
Q1 2020 May 06, 2020	SELL	$82.38 - $131.64 $4,366 - $6,976	-53 Reduced 0.71%	7,416 $725,000
Q4 2019 Jan 21, 2020	SELL	$76.53 - $135.58 $49,514 - $87,720	-647 Reduced 7.97%	7,469 $964,000
Q3 2019 Nov 06, 2019	SELL	$72.81 - $156.91 $70,188 - $151,261	-964 Reduced 10.62%	8,116 $611,000
Q2 2019 Jul 19, 2019	SELL	$112.21 - $151.95 $103,906 - $140,705	-926 Reduced 9.25%	9,080 $1.38 Million
Q1 2019 May 03, 2019	BUY	$106.67 - $151.68 $25,600 - $36,403	240 Added 2.46%	10,006 $1.19 Million
Q4 2018 Jan 30, 2019	BUY	$97.32 - $148.76 $56,932 - $87,024	585 Added 6.37%	9,766 $1.07 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $1.06 Million - $1.48 Million	9,181 New	9,181 $1.48 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.28 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.11 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$777 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$541 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$530 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.

Account